A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment

Drug repositioning is a promising and powerful innovative strategy in the field of drug discovery. In this study, we screened a compound-library containing 800 Food and Drug Administration approved drugs for their anti-leukemic effect. All screening activities made use of human peripheral blood mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehdi, Atef, Samman, Nosaibah, Mashhour, Abdullah, Alhallaj, Alshaimaa, Trivilegio, Thadeo, Gul, Sheraz, Reinshagen, Jeanette, Alaskar, Ahmed, Gmati, Gamal, Abuelgasim, Khadega A., Mansour, Fatmah, Boudjelal, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195271/
https://www.ncbi.nlm.nih.gov/pubmed/34123769
http://dx.doi.org/10.3389/fonc.2021.579488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195271/
https://www.ncbi.nlm.nih.gov/pubmed/34123769
http://dx.doi.org/10.3389/fonc.2021.579488

Ejemplares similares